Abstract:Diverse forms of resistance to anticancer drugs can lead to the failure of chemotherapy. Drug resistance is one of the most intractable issues for successfully treating cancer in current clinical practice. Effective clinical approaches that could counter drug resistance by restoring the sensitivity of tumors to the targeted agents are urgently needed. As numerous experimental results on resistance mechanisms have been obtained and a mass of high-throughput data has been accumulated, mathematical modeling and computational predictions using systematic and quantitative approaches have become increasingly important, as they can potentially provide deeper insights into resistance mechanisms, generate novel hypotheses or suggest promising treatment strategies for future testing. In this review, we first briefly summarize the current progress of experimentally revealed resistance mechanisms of targeted therapy, including genetic mechanisms, epigenetic mechanisms, posttranslational mechanisms, cellular mechanisms, microenvironmental mechanisms and pharmacokinetic mechanisms. Subsequently, we list several currently available databases and Web-based tools related to drug sensitivity and resistance. Then, we focus primarily on introducing some state-of-the-art computational methods used in drug resistance studies, including mechanism-based mathematical modeling approaches (e.g. molecular dynamics simulation, kinetic model of molecular networks, ordinary differential equation model of cellular dynamics, stochastic model, partial differential equation model, agent-based model, pharmacokinetic-pharmacodynamic model, etc.) and data-driven prediction methods (e.g. omics data-based conventional screening approach for node biomarkers, static network approach for edge biomarkers and module biomarkers, dynamic network approach for dynamic network biomarkers and dynamic module network biomarkers, etc.). Finally, we discuss several further questions and future directions for the use of computational methods for studying drug resistance, including inferring drug-induced signaling networks, multiscale modeling, drug combinations and precision medicine.

The resistance mechanism and response prediction of docetaxel

Exploring Specific miRNA-mRNA Axes With Relationship to Taxanes-Resistance in Breast Cancer

Research Development on Drug-Resistance Mechanism of Taxanes

Mechanism and Treatment Associated with Resistance to EGFR-TKI

Mechanisms of Taxane Resistance

Analysis of Tumor Drug Resistance-Associated Proteins by Proteomics Study

Molecular Mechanisms of Chemoresistance and Cytotoxicity Associated with Platinum Drugs

Mechanism of Drug Resistance Identified in Human Lung Adenocarcinoma Cell Line SPC-A1 Selected for Resistance to Docetaxel

Epithelial-mesenchymal Transition Contributes to Docetaxel Resistance in Human Non-Small Cell Lung Cancer.

Molecular mechanisms for tumor resistance to chemotherapy.

Research on the Mechanisms of Docetaxel-Resistant Human Lung Adenocarcinoma

Key genes and molecular mechanisms related to Paclitaxel Resistance

Research Progress in Chemoresistance Mechanism of Paclitaxel and the Future Direction

Recent Advances in Elucidating Paclitaxel Resistance Mechanisms in Non-small Cell Lung Cancer and Strategies to Overcome Drug Resistance.

Resistant Mechanisms of Doxorubicin

Mathematical modeling and computational prediction of cancer drug resistance

Nanoscale drug delivery for taxanes based on the mechanism of multidrug resistance of cancer.

Association of ABCB1, β tubulin I, and III with multidrug resistance of MCF7/DOC subline from breast cancer cell line MCF7

Establishment and Characterization of a Docetaxel-Resistant Variant of Human Lung Adenocarcinoma Cell Line SPC-A1

Role of Apoptosis Inhibition in the Multidrug Resistance of the Human Lung Adenocarcinoma Cell Line SPC-A1/Docetaxel

Identification of Biomarkers, Pathways and Potential Therapeutic Target for Docetaxel Resistant Prostate Cancer